Market Movers Investor Summit May 5, 2026, New York, NY Chief Financial Officer Eyal Rubin will participate in 1x1 meetings. D. Boral Capital Global Conference May 7, 2026, New York, NY Chief ...
TEL AVIV, Israel, Feb. 27, 2025 /PRNewswire/ -- Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based ...
Everyone hates Nasus at one point or other. Even Nasus players hate playing against Nasus. Why? Because he is pure, high-octane bullshit that can 1v5 your entire team if you let him just do his job.
On September 28, 2022, League of Legends released a major number of changes for Nasus in its PBE (Public Beta Environment). It has been a while since Nasus received buffs within the game, but it looks ...
View Nasus Pharma Ltd. NSRX stock quote prices, financial information, real-time forecasts, and company news from CNN.
Nasus is a late bloomer in League of Legends. The champion can be one of the most powerful tanks in the game if players use him correctly. Gamers need to take a conservative approach in the first five ...
After Sivir, Rammus and Garen, Nasus, the Curator of the Sands, is the next champion to get a visual update and an Infernal skin as an addition. Riot continues visually updating old champions. Nasus, ...
Chief Financial Officer Eyal Rubin will participate in 1x1 meetings. Nasus Pharma is a clinical-stage pharmaceutical company developing a number of intranasal powder products addressing acute medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results